IBDEI0RU ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,12532,1,3,0)
;;=3^Infection d/t Indwelling Urethral Catheter,Healing/Subs Encntr
;;^UTILITY(U,$J,358.3,12532,1,4,0)
;;=4^T83.511D
;;^UTILITY(U,$J,358.3,12532,2)
;;=^5140139
;;^UTILITY(U,$J,358.3,12533,0)
;;=T83.511S^^49^603^35
;;^UTILITY(U,$J,358.3,12533,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12533,1,3,0)
;;=3^Infection d/t Indwelling Urethral Catheter,Sequela
;;^UTILITY(U,$J,358.3,12533,1,4,0)
;;=4^T83.511S
;;^UTILITY(U,$J,358.3,12533,2)
;;=^5140140
;;^UTILITY(U,$J,358.3,12534,0)
;;=T83.512D^^49^603^36
;;^UTILITY(U,$J,358.3,12534,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12534,1,3,0)
;;=3^Infection d/t Nephrostomy Catheter,Healing/Subs Encntr
;;^UTILITY(U,$J,358.3,12534,1,4,0)
;;=4^T83.512D
;;^UTILITY(U,$J,358.3,12534,2)
;;=^5140142
;;^UTILITY(U,$J,358.3,12535,0)
;;=T83.512A^^49^603^37
;;^UTILITY(U,$J,358.3,12535,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12535,1,3,0)
;;=3^Infection d/t Nephrostomy Catheter,Init Encntr
;;^UTILITY(U,$J,358.3,12535,1,4,0)
;;=4^T83.512A
;;^UTILITY(U,$J,358.3,12535,2)
;;=^5140141
;;^UTILITY(U,$J,358.3,12536,0)
;;=T83.512S^^49^603^38
;;^UTILITY(U,$J,358.3,12536,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12536,1,3,0)
;;=3^Infection d/t Nephrostomy Catheter,Sequela
;;^UTILITY(U,$J,358.3,12536,1,4,0)
;;=4^T83.512S
;;^UTILITY(U,$J,358.3,12536,2)
;;=^5140143
;;^UTILITY(U,$J,358.3,12537,0)
;;=R97.20^^49^603^18
;;^UTILITY(U,$J,358.3,12537,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12537,1,3,0)
;;=3^Elevated PSA
;;^UTILITY(U,$J,358.3,12537,1,4,0)
;;=4^R97.20
;;^UTILITY(U,$J,358.3,12537,2)
;;=^334262
;;^UTILITY(U,$J,358.3,12538,0)
;;=R97.21^^49^603^19
;;^UTILITY(U,$J,358.3,12538,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12538,1,3,0)
;;=3^Elevated PSA After Prostate CA Treatment
;;^UTILITY(U,$J,358.3,12538,1,4,0)
;;=4^R97.21
;;^UTILITY(U,$J,358.3,12538,2)
;;=^5139228
;;^UTILITY(U,$J,358.3,12539,0)
;;=N18.30^^49^603^9
;;^UTILITY(U,$J,358.3,12539,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12539,1,3,0)
;;=3^Chr Kidney Disease,Stage 3,Unspec
;;^UTILITY(U,$J,358.3,12539,1,4,0)
;;=4^N18.30
;;^UTILITY(U,$J,358.3,12539,2)
;;=^5159286
;;^UTILITY(U,$J,358.3,12540,0)
;;=N18.31^^49^603^10
;;^UTILITY(U,$J,358.3,12540,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12540,1,3,0)
;;=3^Chr Kidney Disease,Stage 3a
;;^UTILITY(U,$J,358.3,12540,1,4,0)
;;=4^N18.31
;;^UTILITY(U,$J,358.3,12540,2)
;;=^5159287
;;^UTILITY(U,$J,358.3,12541,0)
;;=N18.32^^49^603^11
;;^UTILITY(U,$J,358.3,12541,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12541,1,3,0)
;;=3^Chr Kidney Disease,Stage 3b
;;^UTILITY(U,$J,358.3,12541,1,4,0)
;;=4^N18.32
;;^UTILITY(U,$J,358.3,12541,2)
;;=^5159288
;;^UTILITY(U,$J,358.3,12542,0)
;;=B15.9^^49^604^2
;;^UTILITY(U,$J,358.3,12542,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12542,1,3,0)
;;=3^Acute Hepatitis A w/o Hepatic Coma
;;^UTILITY(U,$J,358.3,12542,1,4,0)
;;=4^B15.9
;;^UTILITY(U,$J,358.3,12542,2)
;;=^5000536
;;^UTILITY(U,$J,358.3,12543,0)
;;=B18.2^^49^604^5
;;^UTILITY(U,$J,358.3,12543,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12543,1,3,0)
;;=3^Chronic Viral Hepatitis C
;;^UTILITY(U,$J,358.3,12543,1,4,0)
;;=4^B18.2
;;^UTILITY(U,$J,358.3,12543,2)
;;=^5000548
;;^UTILITY(U,$J,358.3,12544,0)
;;=B17.10^^49^604^4
;;^UTILITY(U,$J,358.3,12544,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0RU 3753 printed Apr 09, 2024@21:20:43 Page 2
IBDEI0RU ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,12532,1,3,0)
+2 ;;=3^Infection d/t Indwelling Urethral Catheter,Healing/Subs Encntr
+3 ;;^UTILITY(U,$J,358.3,12532,1,4,0)
+4 ;;=4^T83.511D
+5 ;;^UTILITY(U,$J,358.3,12532,2)
+6 ;;=^5140139
+7 ;;^UTILITY(U,$J,358.3,12533,0)
+8 ;;=T83.511S^^49^603^35
+9 ;;^UTILITY(U,$J,358.3,12533,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,12533,1,3,0)
+12 ;;=3^Infection d/t Indwelling Urethral Catheter,Sequela
+13 ;;^UTILITY(U,$J,358.3,12533,1,4,0)
+14 ;;=4^T83.511S
+15 ;;^UTILITY(U,$J,358.3,12533,2)
+16 ;;=^5140140
+17 ;;^UTILITY(U,$J,358.3,12534,0)
+18 ;;=T83.512D^^49^603^36
+19 ;;^UTILITY(U,$J,358.3,12534,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,12534,1,3,0)
+22 ;;=3^Infection d/t Nephrostomy Catheter,Healing/Subs Encntr
+23 ;;^UTILITY(U,$J,358.3,12534,1,4,0)
+24 ;;=4^T83.512D
+25 ;;^UTILITY(U,$J,358.3,12534,2)
+26 ;;=^5140142
+27 ;;^UTILITY(U,$J,358.3,12535,0)
+28 ;;=T83.512A^^49^603^37
+29 ;;^UTILITY(U,$J,358.3,12535,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,12535,1,3,0)
+32 ;;=3^Infection d/t Nephrostomy Catheter,Init Encntr
+33 ;;^UTILITY(U,$J,358.3,12535,1,4,0)
+34 ;;=4^T83.512A
+35 ;;^UTILITY(U,$J,358.3,12535,2)
+36 ;;=^5140141
+37 ;;^UTILITY(U,$J,358.3,12536,0)
+38 ;;=T83.512S^^49^603^38
+39 ;;^UTILITY(U,$J,358.3,12536,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,12536,1,3,0)
+42 ;;=3^Infection d/t Nephrostomy Catheter,Sequela
+43 ;;^UTILITY(U,$J,358.3,12536,1,4,0)
+44 ;;=4^T83.512S
+45 ;;^UTILITY(U,$J,358.3,12536,2)
+46 ;;=^5140143
+47 ;;^UTILITY(U,$J,358.3,12537,0)
+48 ;;=R97.20^^49^603^18
+49 ;;^UTILITY(U,$J,358.3,12537,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,12537,1,3,0)
+52 ;;=3^Elevated PSA
+53 ;;^UTILITY(U,$J,358.3,12537,1,4,0)
+54 ;;=4^R97.20
+55 ;;^UTILITY(U,$J,358.3,12537,2)
+56 ;;=^334262
+57 ;;^UTILITY(U,$J,358.3,12538,0)
+58 ;;=R97.21^^49^603^19
+59 ;;^UTILITY(U,$J,358.3,12538,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,12538,1,3,0)
+62 ;;=3^Elevated PSA After Prostate CA Treatment
+63 ;;^UTILITY(U,$J,358.3,12538,1,4,0)
+64 ;;=4^R97.21
+65 ;;^UTILITY(U,$J,358.3,12538,2)
+66 ;;=^5139228
+67 ;;^UTILITY(U,$J,358.3,12539,0)
+68 ;;=N18.30^^49^603^9
+69 ;;^UTILITY(U,$J,358.3,12539,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,12539,1,3,0)
+72 ;;=3^Chr Kidney Disease,Stage 3,Unspec
+73 ;;^UTILITY(U,$J,358.3,12539,1,4,0)
+74 ;;=4^N18.30
+75 ;;^UTILITY(U,$J,358.3,12539,2)
+76 ;;=^5159286
+77 ;;^UTILITY(U,$J,358.3,12540,0)
+78 ;;=N18.31^^49^603^10
+79 ;;^UTILITY(U,$J,358.3,12540,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,12540,1,3,0)
+82 ;;=3^Chr Kidney Disease,Stage 3a
+83 ;;^UTILITY(U,$J,358.3,12540,1,4,0)
+84 ;;=4^N18.31
+85 ;;^UTILITY(U,$J,358.3,12540,2)
+86 ;;=^5159287
+87 ;;^UTILITY(U,$J,358.3,12541,0)
+88 ;;=N18.32^^49^603^11
+89 ;;^UTILITY(U,$J,358.3,12541,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,12541,1,3,0)
+92 ;;=3^Chr Kidney Disease,Stage 3b
+93 ;;^UTILITY(U,$J,358.3,12541,1,4,0)
+94 ;;=4^N18.32
+95 ;;^UTILITY(U,$J,358.3,12541,2)
+96 ;;=^5159288
+97 ;;^UTILITY(U,$J,358.3,12542,0)
+98 ;;=B15.9^^49^604^2
+99 ;;^UTILITY(U,$J,358.3,12542,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,12542,1,3,0)
+102 ;;=3^Acute Hepatitis A w/o Hepatic Coma
+103 ;;^UTILITY(U,$J,358.3,12542,1,4,0)
+104 ;;=4^B15.9
+105 ;;^UTILITY(U,$J,358.3,12542,2)
+106 ;;=^5000536
+107 ;;^UTILITY(U,$J,358.3,12543,0)
+108 ;;=B18.2^^49^604^5
+109 ;;^UTILITY(U,$J,358.3,12543,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,12543,1,3,0)
+112 ;;=3^Chronic Viral Hepatitis C
+113 ;;^UTILITY(U,$J,358.3,12543,1,4,0)
+114 ;;=4^B18.2
+115 ;;^UTILITY(U,$J,358.3,12543,2)
+116 ;;=^5000548
+117 ;;^UTILITY(U,$J,358.3,12544,0)
+118 ;;=B17.10^^49^604^4
+119 ;;^UTILITY(U,$J,358.3,12544,1,0)
+120 ;;=^358.31IA^4^2
